New antibody drug targets Cancer-Related fluid in the lungs
Disease control
Recruiting now
This study tests a new drug called M701, a bispecific antibody, in people with advanced non-small cell lung cancer that has caused fluid buildup in the chest (malignant pleural effusion). The drug is given directly into the chest cavity to target cancer cells and help control the…
Phase: PHASE1, PHASE2 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC